Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.ย
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the worldโs first post-stroke recovery treatment, helping patients to regain functionalย independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.ย
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimerโs Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.ย
Latest News
New Study Reveals Long-Term Healthcare Impact of Pediatric TBI
Meet Moleac at AD/PD 2025: Advancing Alzheimerโs Care in Vienna
Moleac will be attending the International Conference on Alzheimerโs and Parkinsonโs Diseases (AD/PD) from April 1หขแต to 5แตสฐ, 2025, in Vienna.
Stronger Together: Wrapping Up Our Global Affiliates Convention in France
Marching Forward for Brain Injury Awareness: Promoting Recovery and Hope
Advancing Neurological Care: Highlights from the Lisbon Symposium
Last month, we hosted a Neurology Symposium in Lisbon, bringing together leading experts in stroke, brain injury, and dementia.
Empowering Recovery: Celebrating Brain Injury Awareness Month with Moleac
Plasma p-tau217: A Game-Changer for Early Alzheimerโs Diagnosis in East Asia!
This recent study by Lin Y-S et al. evaluated plasma p-tau217 and p-tau181 levels in Korean and Taiwanese populations.
Building Partnerships & Shaping the Future: Highlights from Our Affiliates Convention in Singapore!
Wrapping up a memorable Affiliates Convention in Singapore!
Empowering Stroke Care: Join Moleac & ASAP for a Blood Pressure Webinar
๐ข Weโre Now on Instagram! Follow @moleacneuro for Exclusive Updates!
Exciting News! We are expanding our digital presence to bring you even closer to our journey. Moleac is now on Instagram!
